Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Raknerud

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Scandinavian Journal of Gastroenterology|February 15, 2002
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre studyK Bjøro, H Bell, K B Hellum, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct GroupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Gastroenterology|February 24, 2001
The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjectsH Bell, J P Berg, D E Undlien, et al.
Scandinavian Journal of Gastroenterology|March 28, 2002
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre studyK Bjøro, H Bell, B Myrvang, et al.
Scandinavian Journal of Gastroenterology|March 28, 1998
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT GroupL M Jarvis, H Bell, P Simmonds, et al.
Scandinavian Journal of Gastroenterology|April 7, 1999
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT GroupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct groupH Bell, K Hellum, S Harthug, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Scandinavian Journal of Gastroenterology|February 15, 2002
Effect of combined interferon-alpha induction therapy and ribavirin on chronic hepatitis C virus infection: a randomized multicentre studyK Bjøro, H Bell, K B Hellum, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1996
Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct GroupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Gastroenterology|February 24, 2001
The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjectsH Bell, J P Berg, D E Undlien, et al.
Scandinavian Journal of Gastroenterology|March 28, 2002
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre studyK Bjøro, H Bell, B Myrvang, et al.
Scandinavian Journal of Gastroenterology|March 28, 1998
The effect of treatment with alpha-interferon on hepatitis G/GBV-C viraemia. The CONSTRUCT GroupL M Jarvis, H Bell, P Simmonds, et al.
Scandinavian Journal of Gastroenterology|April 7, 1999
Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT GroupH Bell, K Hellum, S Harthug, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct groupH Bell, K Hellum, S Harthug, et al.
Pageof 5